NewJour Home |
NewJour: I |
Search
[Subject Prev] [Subject Next]
Immunopharmacology
Cynthia Reid wrote:
From: "Cynthia Reid" <CynthiaReid@worldnet.att.net>
Subject: Immunopharmacology
Date: Mon, 21 Aug 2000 02:02:24 -0400
Immunopharmacology
Note: Incorporated into International Immunopharmacology
Content available to subscribers at:
http://www.sciencedirect.com/science/journal/15675769
Content prior to October 2000 available to subscribers at:
http://www.sciencedirect.com/science/journal/01623109
http://www.elsevier.com/locate/immpharm
(Link inactive 22 November 2004)
Immunopharmacology is the primary vehicle for the swift publication of
original research papers pertinent to the overlapping areas of immunology,
pharmacology, and toxicology. Review articles that encompass these subjects
material are also welcomed and will be featured.
The subject material appropriate for submission includes:
- pharmacological compounds, microbial products and toxicological agents
which affect the lymphoid system, and their mechanisms of action;
- agents which activate genes or modify transcription and translation;
- substances which improve or are involved in causing carcinoma, autoimmune
diseases and immunological deficiencies;
- substances released through immunologic or related pathways that are
pharmacologically active
- production and function of cytokines and their receptors;
- other cell-derived factors that modify the immune system causing
cytotoxicity, producing antibodies and mediating inflammatory responses;
- immunotherapy and immunotoxicology contributions not covered by the above.
Submissions may be sent directly to any of the Editors listed. The various
special field(s) of each editor are provided as a guide, particularly to
help expedite the reviewing process.
Audience: Immunologists, pharmacologists, biochemists, toxicologists
Table of contents and abstracts are available in HTML format without a
subscription. ScienceDirect subscribers have access to full-text articles
by logging in at http://www.sciencedirect.com .
Editor-in-Chief: T.E. Hugli
Email: hugli@scripps.edu
NewJour Home |
NewJour: I |
Search
[Subject Prev] [Subject Next]